Heron Financial Group, LLC Biogen Inc. Transaction History

Heron Financial Group, LLC

$185 Million
Q2 2023

A detailed history of Heron Financial Group, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Heron Financial Group, LLC holds 1,745 shares of BIIB stock, worth $217,706. This represents 0.27% of its overall portfolio holdings.

Number of Shares

1,745

Previous 1,710 2.05%

Holding current value

$217,706

Previous $475,000 4.63%

% of portfolio

0.27%

Previous 0.26%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$275.25 - $318.06 $9,633 - $11,132	35 Added 2.05%	1,745 $497,000
Q1 2023 Apr 19, 2023	BUY	$256.56 - $292.34 $2,822 - $3,215	11 Added 0.65%	1,710 $475,000
Q3 2022 Oct 27, 2022	SELL	$194.69 - $268.46 $40,884 - $56,376	-210 Reduced 11.0%	1,699 $454,000
Q2 2022 Jul 29, 2022	BUY	$187.54 - $223.02 $43,134 - $51,294	230 Added 13.7%	1,909 $389,000
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $17,439 - $21,972	-90 Reduced 5.09%	1,679 $354,000
Q4 2021 Feb 04, 2022	SELL	$223.92 - $287.77 $10,748 - $13,812	-48 Reduced 2.64%	1,769 $406,000
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $2,362 - $3,556	10 Added 0.55%	1,817 $455,000
Q3 2020 Oct 15, 2020	SELL	$264.77 - $305.71 $11,914 - $13,756	-45 Reduced 2.43%	1,807 $514,000
Q2 2020 Jul 20, 2020	BUY	$258.66 - $342.55 $4,655 - $6,165	18 Added 0.98%	1,852 $516,000
Q1 2020 Apr 23, 2020	SELL	$268.85 - $341.04 $14,517 - $18,416	-54 Reduced 2.86%	1,834 $612,000
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $415,473 - $574,084	1,888 New	1,888 $627,000

Others Institutions Holding BIIB

# of Institutions

1,026

Shares Held

127M

Call Options Held

2.29M

Put Options Held

4.26M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $18B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Heron Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Heron Financial Group, LLC with notifications on news.

Account

Heron Financial Group, LLC Biogen Inc. Transaction History